Additionally, in bladder cancer, the JNK signaling pathway promotes the expression of thymic stromal lymphopoietin in CAFs, which inhibits CD8+ T cell cytotoxicity and effector functions, ultimately contributing to immunotherapy resistance [178]. The gene discussed is CD8A; the disease is urinary bladder carcinoma.